Respiratory Dysfunction and Sleep-Disordered Breathing in Children With Myasthenia Gravis.


Journal

Journal of child neurology
ISSN: 1708-8283
Titre abrégé: J Child Neurol
Pays: United States
ID NLM: 8606714

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 3 6 2020
medline: 4 11 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

The purpose of this study was to prospectively evaluate sleep patterns and the presence of sleep-disordered breathing in children with myasthenia gravis. We further aimed to examine the relationship between sleep and daytime respiratory function using spirometry tests including upright and supine forced vital capacity, sniff nasal inspiratory pressure, and maximal inspiratory pressure. Eleven children between 3 and 18 years old with confirmed myasthenia gravis were recruited from The Hospital for Sick Children Neuromuscular Clinic in this prospective observational study. After informed consent was obtained, patients underwent a comprehensive clinical assessment with collection of anthropometric data. Following this, all subjects performed pulmonary function tests, overnight polysomnography and completed the Epworth Sleepiness Scale questionnaire. Two of eleven children who reported no symptoms of sleep disordered breathing were diagnosed with mild to moderate obstructive sleep apnea. Pulmonary function tests showed abnormal maximal inspiratory pressure in 6 of 11 patients, whereas seated forced vital capacity as well as seated to supine forced vital capacity ratios were normal in the entire group. In our small group of pediatric myasthenia gravis subjects, there was an unexpected finding of obstructive sleep apnea in 2 of the 11 patients studied. Maximal inspiratory pressure appears to be a more sensitive method of detecting abnormalities compared to upright or seated forced vital capacity. A larger multicenter study is needed to validate our findings and to determine the impact of obstructive sleep apnea in the pediatric myasthenia gravis population as well as risk factors associated with sleep disordered breathing.

Identifiants

pubmed: 32484036
doi: 10.1177/0883073820924213
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-606

Auteurs

Hans D Katzberg (HD)

Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.

Jiri Vajsar (J)

Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.

Kevin Vezina (K)

Department of Pediatrics, Division of Respirology, University of Toronto, Toronto, Ontario, Canada.

Heba Qashqari (H)

Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.

Sarah Selvadurai (S)

Department of Pediatrics, Division of Respirology, University of Toronto, Toronto, Ontario, Canada.

Nicholas Chrestian (N)

Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.

Abdullah Khayat (A)

Department of Pediatrics, Division of Respirology, University of Toronto, Toronto, Ontario, Canada.

Clodagh M Ryan (CM)

Department of Medicine, Division of Respirology, University of Toronto, Toronto, Ontario, Canada.

Indra Narang (I)

Department of Pediatrics, Division of Respirology, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH